Cardiac |
Acute cardiac injury (8–12%), heart failure (23–52%), arrhythmia (8.9–16.7%), shock, acute myocarditis, chest tightness |
[8,[7], [8], [9], [10], [11], [12], [13], [14]] |
Gastrointestinal |
Anorexia (26.8%), diarrhoea (12.5%), nausea/vomiting (10.2%), abdominal pain/discomfort (9.2%) |
[[18], [19], [20],24,25,27,28]
|
Hepatic |
Abnormal aspartate aminotransferase or alanine aminotransferase values (16.1–53.1%) |
[8,10,[21], [22], [23], [24], [25], [26]] |
Kidney |
Acute kidney injury (overall 0.5%; 2.9–23% in severe cases) |
[10,24,25]
|
Neurological |
Dizziness (16.8%), headache (13.1%), skeletal muscle injury (10.7%), impaired consciousness (7.5%), acute cerebrovascular disease (2.8%), ataxia (0.5%), seizures (0.5%), meningoencephalitis, Guillain–Barré syndrome |
[31], [32], [33], [34]
|
Olfactory and gustatory |
Hyposmia (5.1–20.4%), anosmia (79.6%), dysgeusia (8.5%), ageusia (1.7%) |
[24,25,39,40]
|
Ocular |
Acute conjunctivitis (31.6%) |
[44,45]
|
Cutaneous |
Erythematous rash (15.9%), hives rash (3.4%), vesicles (1.1%), acro-ischaemia, transient unilateral livedo reticularis |
[25,[49], [50], [51], [52]] |
Haematological |
Lymphopenia (56.5%), thrombocytopenia (16.4–32.3%), coagulation disorders, thrombotic events, antiphospholipid antibody |
[53], [54], [55], [56], [57], [58], [59]
|